Understanding TZIELD cost and coverage
Ensuring that TZIELD is accessible and affordable for all eligible patients is a priority. If you have questions about TZIELD cost or coverage or need support throughout your autoimmune type 1 diabetes (T1D) screening or treatment journey, the resources on this page can help.
Most patients can access financial support for treatment, but what you pay for TZIELD depends on a few factors:
Your type of insurance coverage
Whether you have prescription drug insurance
If you've met your insurance deductible
92% of US patients with commercial insurance or with Medicaid are covered nationally for TZIELD
As little as $0 copay may be available
With the TZIELD Copay Program*, eligible, commercially insured patients may pay as little as $0 for treatment.
The TZIELD COMPASS Patient Support Program can provide details about this program and help you explore other available financial assistance options.
Call today to speak with a team member 1-844-778-2246 Monday through Friday, 8 AM–8 PM ET
*The TZIELD Copay Program is not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs including any state pharmaceutical assistance programs. Not valid where prohibited by law, taxed, or restricted. Sanofi reserves the right to rescind or amend this offer, eligibility, and terms of use at any time without notice. Upon registration, patients receive all Program details.
Eligibility requirements and terms and conditions apply. Terms & conditions.
TZIELD cost and coverage guide
Select your insurance to see your potential out-of-pocket costs.
What do most people with commercial insurance pay for TZIELD?
96% of patients with commercial insurance are covered for TZIELD with the TZIELD Copay Program, but out-of-pocket costs (OOPs) vary based on your specific plan*.
With the TZIELD Copay Program, You Could Pay as Little as $0†
The TZIELD COMPASS team can provide details about this program and help you explore other available financial assistance options.
Call today to speak with a team member. 1-844-778-2246 Monday through Friday, 8 AM–8 PM ET
Must be US residents with an FDA-approved prescription for TZIELD. Other eligibility requirements and terms and conditions apply.
Terms & conditions.* Formulary data are provided by Managed Markets Insight & Technology, LLC and are current as of [MM/YYYY]
†Approval is not guaranteed. Program has an annual maximum of [$22,000]. THIS IS NOT INSURANCE. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs including any state pharmaceutical assistance programs. This program is not valid where prohibited by law, taxed or restricted. Sanofi reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Any savings provided by the program may vary depending on patients' out-of-pocket costs. The program is intended to help patients afford TZIELD. Patients may have insurance plans that attempt to dilute the impact of the assistance available under the program. In those situations, the program may change its terms. Additional terms and conditions apply.
What do most people with Medicaid pay for TZIELD?
80% of patients with Medicaid are covered for TZIELD, but out-of-pocket costs (OOPs) vary based on your specific plan*.
To find out if you qualify for Medicaid, or for more information about copays under Medicaid in your state, visit the Medicaid site.
If you need help paying for your prescription, The TZIELD COMPASS may be able to help. The TZIELD COMPASS team can research each patient's situation and determine eligibility.†
For more information on insurance coverage, call TZIELD COMPASS at 1-844-778-2246 Monday through Friday, 8 AM–8 PM ET
*Formulary data are provided by Managed Markets Insight & Technology, LLC and are current as of MM/YYYY
†Maximum allowable copayments determined by eligible population’s household income
What do most people with Medicare pay for TZIELD?
TZIELD falls under Medicare Part B, which means you typically pay a 20% coinsurance for most covered medical services after meeting an annual deductible.
Cost Assistance Options
Medigap/supplemental insurance can help cover additional costs (many patients may pay as little as $0 in these cases). Visit the Medicare site to learn more.
Speak with the TZIELD COMPASS team to see if other financial assistance is available. Dial 1-844-778-2246 Monday through Friday, 8 AM–8 PM ET
*Payments are averaged across all phases of Medicare coverage, and include coverage gap and catastrophic phase payments. Out-of-pocket costs were standardized to a 14-day supply period.
What do most people with these types of insurance pay for TZIELD?
Out-of-pocket costs for these types of insurance vary by plan.
If you need assistance paying for your prescription, the TZIELD COMPASS team may be able to help cover the cost of TZIELD. The TZIELD COMPASS Patient Support Program can help assess and determine patient eligibility*. For more information on insurance coverage, call TZIELD COMPASS at 1-844-778-2246 Monday through Friday, 8 AM–8 PM ET.
*Maximum allowable copayments determined by eligible population’s household income
What do most people who are uninsured or underinsured pay for TZIELD?
If you do not have insurance that covers your prescription medications, or if your insurance does not cover TZIELD, you can typically expect to pay the list price, plus any additional specialty pharmacy charges.
The TZIELD COMPASS team may be able to provide financial assistance to help pay for your prescription*. Call today to speak with a team member to see if you're eligible. 1-844-778-2246 Monday through Friday, 8 AM–8 PM ET
*Patients will need to meet the eligibility criteria, including household income, to qualify. Call today to speak with a team member who can help.
Frequently Asked Questions
Understanding Your Potential T1D Screening Costs
Autoantibody (AAb) screening, a test that is not included in annual blood work, offers the opportunity to identify, monitor and potentially treat T1D before symptoms appear. AAb screening costs can vary depending on the type of insurance you have.
8 out of 10 commercially insured patients pay less than $20* for type 1 diabetes AAb screening
Learn more about AAb screening
*n=[2114]. Analysis has been conducted using LAAD Medical and Remittance data from [May 2023] to [April 2024]. Includes commercial claims with one of the following current procedural technology (CPT) codes: 86341 and/or 86337. Note: The analysis does not differentiate between the number of AAbs tested within each claim.
Important Safety Information and Approved Use
What is the most important information I should know about TZIELD? TZIELD may cause serious side effects. These include:- Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea, feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD
- Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes
Your healthcare provider will do blood tests to check your liver and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection, or if your blood counts stay too low.
What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:- have a serious infection or an infection that does not go away or keeps coming back
- have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your doctor that you are receiving TZIELD before receiving a vaccine
- are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy
- are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of TZIELD? The most common side effects of TZIELD include:- rash
- leukopenia (decrease in white blood cell counts)
- headache
These are not all of the possible side effects of TZIELD. Talk to your healthcare provider for more information, and tell them about any side effects you notice. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
Please see Medication Guide and Prescribing Information.
What is TZIELD?
TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 8 years of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes.
It is not known if TZIELD is safe and effective in children under 8 years of age.
Important Safety Information and Approved Use
- Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea, feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD
- Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes
Your healthcare provider will do blood tests to check your liver and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection, or if your blood counts stay too low.
What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:- have a serious infection or an infection that does not go away or keeps coming back
- have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your doctor that you are receiving TZIELD before receiving a vaccine
- are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy
- are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of TZIELD? The most common side effects of TZIELD include:- rash
- leukopenia (decrease in white blood cell counts)
- headache
These are not all of the possible side effects of TZIELD. Talk to your healthcare provider for more information, and tell them about any side effects you notice. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.
Please see Medication Guide and Prescribing Information.
What is TZIELD?
TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 8 years of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes.
It is not known if TZIELD is safe and effective in children under 8 years of age.